Effect of Glargine Insulin Delivery Method (Pen-Device vs. Vial-Syringe) on Glycemic Control

Patients switching to glargine pen achieved lower HbA1c at 6 months of follow-up. Patients in both groups overwhelmingly preferred glargine pens over vial-syringe (Endocrine Practice)